newsfilter
← Latest News
GlobeNewswire·

Cyclerion Therapeutics Hosted Webinar to Discuss Pipeline Progress

Provided updates on development strategy and execution for CY6463, a first-in-class, CNS-penetrant sGC stimulator, including IND clearance from FDA in ADv and ongoing MELAS program Introduced new CY6463 clinical program in CIAS with k